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Abstract 
There is a worsening epidemic of obesity and diabetes in the world. Life style interventions including dietary changes 
and increase in exercise can improve glucose metabolism and health in general. However, standard exercise programs 
are strenuous, time-consuming, and thus have low long-term compliance issues. We tested the feasibility of using 
high frequency, low amplitude whole body vibration (WBV) therapy to improve glucose metabolism in young type 
2 diabetic (T2DM) mice. We also aimed to investigate the postulated anti-inflammatory and cytoprotective proper-
ties of WBV. Male db/db and db/m mice were exposed to high frequency, low-amplitude WBV. Outcome param-
eters comprised of body weight, hemoglobin A1c (HbA1c) level, as well as interleukin (IL)-17 (a marker of helper T 
cells), forkhead box P3 (Foxp3; a marker of regulatory T cells), and gammaH2AX (an index of DNA injury) expression. 
Furthermore, a 24 h metabolic cage study was carried out immediately after the WBV protocol and fluid intake, urine 
excretion and urine osmolality were determined. WBV did not affect body weight but improved HbA1c levels in db/
db mice. Vibrated db/db mice demonstrated less fluid intake and urine excretion but better urinary concentrating 
ability than their non-vibrated controls. Pro-inflammatory changes were significantly reduced, as indicated by reduced 
IL-17 but increased Foxp3 expression. WBV reduced gammaH2AX in db/db mice suggestive of cytoprotective effect. 
However, WBV was largely without significant effects on assessed parameters in db/m mice. Collectively, our findings 
suggest that daily, short duration WBV may improve glycemic control, polydipsia, polyuria, and urine osmolality in 
T2DM in association with reduced inflammation. Thus, WBV may be a viable adjunctive treatment strategy in T2DM.
© 2015 Yin et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made.
Background
An unintended but inevitable consequence of decrease 
in physical labor and increase in productivity in centu-
ries following the industrial revolution is the progressive 
uncoupling between caloric intake and energy expendi-
ture, with the former exceeding the later. The trend of 
excess caloric intake and reduction in food variety accel-
erated in the latter part of the twentieth century. This 
phenomenon combined with a progressively more sed-
entary life style was predicted in the 1980s to create a 
perfect storm of explosive rise in the so called Lifestyle-
Related Chronic Diseases such as hypertension, diabetes, 
atherosclerotic cardiovascular diseases and obesity 
(Eaton et  al. 1988). Diabetes is already the fifth-leading 
cause of death in the US, with mortality rates increasing 
by 45 % since 1987. From 1980 to 2010, the prevalence of 
diabetes has increased by 300 %, according to data from 
the Center for Disease Control and Prevention (Roger 
et al. 2011). Further, according to the National Diabetes 
Statistics Report (2014), an estimated 29.1 million Amer-
ican are afflicted with diabetes mellitus, 8.1 million of 
whom are undiagnosed; the vast majority of these indi-
viduals have type 2 diabetes mellitus (T2DM).
T2DM is characterized by excessive hepatic glucose 
release, central obesity, impaired pancreatic insulin 
secretion and decreased insulin sensitivity by target cells 
leading to insulin resistance with chronic and persis-
tent hyperglycemia. Peripheral insulin resistance occurs 
because of impaired insulin-induced signal transduction 
that normally causes membrane translocation of glucose 
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transporters such as GLUT4 from the cytosol (Hughes 
et al. 1993). GLUT4 is specific to skeletal muscle cells and 
adipocytes, facilitating insulin stimulated movement of 
glucose into the cell.
Many studies have shown that exercise improves gly-
cemic control in patients with T2DM (Baum et al. 2007; 
Davis and Holm 2012). This beneficial effect is likely 
multifactorial, including increasing energy expendi-
ture as well as insulin-induced membrane transloca-
tion of GLUT4. In addition, a number of studies have 
shown that exercise improves glycemic control in 
T2DM patients and in animal models, in part, due to 
anti-inflammatory properties (Teixeira-Lemos et  al. 
2011; de Lemos et  al. 2007; Teixeira de Lemos et  al. 
2009). However, sustained exercise routine is strenuous, 
time consuming, and difficult to maintain given today’s 
rapid paced digital society (Unick et  al. 2010). There is 
a great need to increase the efficiency and compliance 
of conventional exercises, achieving the euglycemic and 
other health benefits of exercise without the vigor and 
duration of standard exercise intervention programs 
(Brownell 1986). Because exercises and whole body 
vibrations both exert mechanical stresses on the skel-
eton, whole body vibration (WBV) therapy may be one 
answer to such exercise modifications. We investigated 
the effects of standard high frequency, low-amplitude 
synchronous vertical WBV delivered by a commercially 
available platform in young adult db/db mice, a model 
of T2DM, with the objective of answering the following 
questions:
1. Is there an effect of WBV on body mass?
2. Can WBV reduce HbA1c in diabetic mice?
3. What is the effect of WBV on indices of kidney func-
tion (a major target of T2DM)?
4. Can WBV improve circulating inflammatory profile 
and reduce cell damage?
Methods
Animals
Eight-week-old male db/m and db/db mice were obtained 
from the Jackson Laboratories (Boston, MA, USA) and 
housed in the laboratory animal facilities at the Georgia 
Health Sciences University. The use of animals for these 
studies were in accordance with ethical standards and 
was approved by the Institutional Animal Care and Use 
Committee.
Vibrating design and fabrication
To deliver synchronous vertical whole body vibration 
(WBV) with controlled amplitude and frequency, we 
used a commercially available standard WBV machine 
offering 12 speeds (Vibratone AB-760, Hacienda Heights, 
California 91745, USA). We selected speed 1 (frequency: 
30 Hz; amplitude: 3 mm) for 20 min/day for 5 days per 
week for 6  weeks. The amplitude is the maximum dis-
placement distance of the platform surface on which the 
mice were placed. The frequency of 30 Hz and magnitude 
of 0.5–1.5× gravitation (4.9–14.7 m/s2) were verified by 
accelerometer. Figure  1 shows a picture of the custom-
designed vibrating platform used in this study.
Effects of WBV in diabetic and non‑diabetic mice
To test the effects of WBV, four groups of male mice (i.e., 
db/db mice, a model for T2DM, and their non-diabetic 
non-obese db/m controls) were used at 2 months of age 
(n = 6 animals/group): non-vibrated db/db; vibrated db/
db; non-vibrated db/m; vibrated db/m. After 6  weeks, 
the animals were individually placed in metabolic cages 
to monitor water intake, urine excretion and subsequent 
measurement of urine osmolality. HbA1c levels were 
measured from blood collected at the time of sacrifice 
(A1CNow, Bayer HealthCare, LLC, Tarrytown, NY, USA).
Effects of WBV in the weight of Diabetic and non‑diabetic 
mice
To determine the effects of WBV on the body weight, 
experimental animals were weighed before and after 
commencement of WBV at one-week interval for a total 
of 7 times.
Assessment of inflammation and cell death
For the assessment of parameters of interest, fluores-
cence-accelerated cell sorting (FACS) of whole blood was 
performed, using FACSCalibur flow cytometer (BD Bio-
Sciences, San Diego, CA, USA), as previously described 
(Baban et  al. 2013a, b, c). In brief, cells were washed 
twice with cold phosphate-buffered saline and then 
Fig. 1 Picture of vibrating platform capable of delivering the pre-
scribed high frequency, low amplitude vibration (“Methods”)
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resuspended in binding buffer and gently vortexed before 
incubation with IL-17, Foxp3, or gammaH2AX antibod-
ies. Cells were analyzed by flow cytometry within 1  h 
after adding binding buffer.
Antibodies and kits
Antibodies against the pro-inflammatory cytokine IL-17, 
as well as the anti-inflammatory marker Foxp3 were 
purchased from EBIOSCIENCE (San Diego, CA, USA), 
whereas gammaH2AX antibody was obtained from Cell 
Signaling (Denver, MA, USA).
Statistical analysis
Data were analyzed using the analysis of variance 
(ANOVA) followed by Newman-Keuls post hoc test to 
establish significance (p < 0.05) among the groups. Fur-
ther body weights were analyzed by repeated measure 
ANOVA. Data are expressed as mean ± SD.
Results
Effects of WBV on the weight of db/db and db/m mice
As expected, body weight of db/m mice was signifi-
cantly (p  <  0.05) lower than that of db/db mice during 
the course of the study (Fig. 2). Vibrated db/db mice dis-
played a reduction, albeit non-significant, in body weight 
after 1  week of WBV. Thereafter, however, body weight 
was similar between vibrated and non-vibrated db/db 
mice. Similar to db/db mice, WBV did not markedly 
affect body weight of db/m mice.
Effects of WBV on glucose metabolism in 8‑week‑old db/db 
and db/m mice
As shown in Fig.  3, HbA1c levels were significantly 
higher in the db/db than db/m mice. WBV reduced 
HbA1c (about 22  %; p  <  0.05) in vibrated than 
non-vibrated db/db mice. On the other hand, WBV did 
not affect HbA1c level in db/m mice. Due to the small 
sample size, the effect size index was calculated based on 
Cohen’s d formula (Kenny 1987). The effect of interven-
tion is considered large if the Effect Size Index is more 
than 0.8, moderate for 0.5, and small for less than 0.2. 
The Effect Size Index for the decrease in HbA1c in db/
db mice is large (1.97), indicating a high likelihood of 
reproducibility.
Effects of WBV on indices of kidney function in 8‑week‑old 
db/db and db/m mice
In the non-diabetic non-obese db/m mice, WBV 
increased fluid intake but it did not affect urine out-
put or urine osmolality (Table  1). On the other hand, 
WBV reduced fluid intake by about 25 % in db/db mice. 
Vibrated db/db mice also excreted less urine. Moreover, 
WBV improved urinary concentrating ability as demon-
strated by a 28 % increase in urine osmolality in vibrated 
db/db mice (Table 1). Collectively, the results indicate a 
prominent effect of WBV on urinary parameters in db/
db, than db/m, mice as also revealed by larger effect sizes 
indicating a high likelihood of reproducibility (Table 1).
Effects of WBV on inflammation and cell damage
In order to investigate the postulated anti-inflammatory 
effects of WBV, whole blood of experimental animals at 
the end of the experiment were analyzed for IL-17 and 
Foxp3 expression (Figs.  4, 5); IL-17 is a pro-inflamma-
tory cytokine and a marker of T helper cells, whereas 
Foxp3 serves as an anti-inflammatory marker of regula-
tory T cells (Aarvak et al. 1999; Zhang and Zhao 2007). 
Figure 4 depicts representative flow cytometry panels, for 
each experimental group, identifying CD4+  cells which 
were subsequently identified as those positive for IL-17 
Fig. 2 Body weight was significantly (p < 0.05) higher in db/db than 
db/m mice during the course of the study; data are mean ± SD of 6 
animals/group
Fig. 3 HbA1c levels of non-vibrated and vibrated db/m and db/db 
mice; data are mean ± SD of n = 6 animals for each group. *p < 0.05 
compared to their respective db/m controls. **p < 0.05 compared to 
their non-vibrated counterparts
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and FoxP3. As shown in Fig.  5, while there is a signifi-
cant difference in both IL-17 (panel a) and Foxp3 (panel 
b) expressing cells between db/m and db/db mice, WBV 
was without significant effects on these parameters in 
db/m mice. On the other hand, IL-17 positive cells were 
significantly reduced in the vibrated than non-vibrated 
db/db mice. Further, Foxp3 positive cells were showed a 
mild increase in vibrated than non-vibrated db/db mice. 
Table 1 The metabolic cage results from db/m with and without WBV; data are mean ± SD of n = 3 animals/group
* p < 0.05 compared to their db/m counterparts
# p < 0.05 compared tp their non-vibrated counterparts
Fluid intake (mL/24 h) Urine excretion (mL/24 h) Urine osmolality (mOsmol/kg)
db/m
Non-vibrated
1.33 ± 0.58 0.43 ± 0.06 2480.0 ± 303.2
db/m
vibrated
1.00 ± 0.00# 0.30 ± 0.17 3628.5 ± 691.0
db/db
Non-vibrated
21. 00 ± 0.00* 17.00 ± 1.00* 1084.17 ± 65.26*
db/db
Vibrated
15. 67 ± 1.53*,# 13.33 ± 1.53*,# 1387.50 ± 133.30*,#
Size effect index; non-vibrated vs. vibrated db/m 1.94 1.07 1.59
Size effect index; non-vibrated vs. vibrated db/db 1.90 1.73 1.74
Fig. 4 Representative FACS dot plots of IL-17 and FoxP3 positive T cells in vibrated and non-vibrated db/m and db/db mice. CD4+ T cells of periph-
eral blood from experimental groups were further identified as those positive for IL-17 and FoxP3
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In order to determine whether WBV reduces cell injury, 
we determined expression of gammaH2AX which is a 
marker of DNA injury (Kuo and Yang 2008; Mozaffari 
et al., 2012). As shown in Fig. 6, db/db mice showed sig-
nificant increase in gammaH2AX expression in db/db 
than db/m mice, irrespective of WBV treatment. How-
ever, the percent of whole blood cells which were posi-
tive for gammaH2AX were markedly reduced in vibrated 
than non-vibrated db/db mice.
Discussion
Likely driven by global climatic changes, human energy 
metabolism evolved some 3–4 million years ago at a 
time when fat and protein intakes were sporadic, unpre-
dictable, and very energy-requiring (Ungar et  al. 2006). 
With the appearance of tool making during the Pliocene 
Epoch, the ability to hunt terrestrial mammals and to 
break cranial and long bones of the prey permitted the 
early hominins to access food sources high in polyun-
saturated fats from brain and bone marrow. Because of 
the unpredictability and high energy expenditure of such 
food sources, the ability to store energy by converting 
excess macronutrients into adipose tissue conveyed great 
survival advantages for the individual (Hockett and Haws 
2003). However, with the readily available high fat, high 
carbohydrate fast foods, and generally reduced reliance 
on physical vigor in today’s environment, there is a vast 
and persistent discrepancy between caloric intake and 
energy expenditure, resulting in ever increasing preva-
lence and incidence of obesity. Associated with this is 
an unrelenting rise in the incidence of many chronic dis-
eases, including hypertension, atherosclerotic cardiovas-
cular diseases, and T2DM (Mokdad et  al. 2003). Based 
on large epidemiological and econometric studies, the 
negative impact of these chronic diseases, many of which 
are lifestyle-related, is very significant, consuming an 
estimated 75 % of the entire healthcare budget in devel-
oped countries by the early 2000s (Suhrcke et  al. 2006). 
Even though the benefits of standard exercise interven-
tion programs in improving serum glucose clearance 
have been well-documented, compliance rate is low and 
recidivism rate is high, because exercise is strenuous and 
time-consuming resulting in low compliance with such 
recommendation (Jakicic 2012).
During exercise, parts of the skeleton undergo cyclic 
strain from stresses produced by muscle contractions and 
gravitation. This creates fluid flow within the strain-mag-
nifying lacuno-canalicular systems of the bone with oste-
ocytes experiencing shear stress in the range of 0.8–3 Pa 
(Burger and Klein-Nulen 1999). Such cyclic shear stress 
in this biological microfluidic poro-visco-elastic com-
posite is an important stimulus for osteocytes to signal 
osteoblasts to synthesize and release bone specific pro-
teins including osteocalcin, a glutamate-rich protein 
previously thought to be a structural protein (Nomura 
and Takano-Yamamoto 2000). Under acidic conditions, 
the glutamic acid residue of a small fraction of osteo-
calcin escapes gamma carboxylation, and the under 
Fig. 5 FACS analysis of IL-17 (a) and Foxp3 (b) positive cells of peripheral blood obtained from vibrated and non-vibrated db/m and db/db mice; 
data are mean ± SD of percent of CD4+ cells of n = 6 mice/group. *p < 0.05 compared to their respective db/m controls. **p < 0.05 compared to 
their non-vibrated counterparts
Fig. 6 FACS analysis of γH2AX (gamma-H2AX) expression of vibrated 
vs. non-vibrated db/m and db/db mice; data are expressed as 
mean ± SD of percent of total peripheral blood cells (n = 6 animals/
group). *p < 0.05 compared to their respective db/m controls. 
**p < 0.05 compared to their non-vibrated counterparts
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gamma-carboxylated osteocalcin enters the circulation 
to serve very important endocrine functions, includ-
ing increasing insulin sensitivity and responsiveness 
(Prats-Puig et al. 2010). Osteocalcin knockout mice have 
been shown to develop central obesity, hypertension, 
and impaired glucose tolerance (Lee et  al. 2007). Bone, 
in addition to being the rigid structural support for the 
body, is now considered an important endocrine organ 
(Motyl et  al. 2010; Schwartz et  al. 2012). Whatever the 
mechanism, how to modify current exercise programs 
to increase their effectiveness and efficiency is critically 
important if such modality is ever to achieve generalized 
acceptance and improved compliance. There are many 
large cross-sectional, population-based studies correlat-
ing better glycemic control and lipid metabolism in indi-
viduals with higher serum osteocalcin levels (Zhou et al. 
2009). In a cross-sectional clinical study, higher osteocal-
cin level was highly and significantly correlated to better 
body mass index, insulin sensitivity as well as fasting glu-
cose and insulin levels (Pittas et al. 2009).
WBV has been used in cosmonaut training by the Rus-
sian space program for decades and is well-adopted in 
European exercise centers (Rittweger 2010). In a clinical 
report from Germany in 2007, conducted in 40 elderly 
patients with T2DM, best glycemic control was found in 
the WBV group compared to other conventional exer-
cises. Using daily horizontal swing type WBV at 30  Hz 
and 2  mm maximum amplitude for 3  weeks, the inves-
tigators found a decrease in fasting peak glucose con-
centration of 6.3  % using oral glucose tolerance testing 
(Baum et al. 2007). Vibration of the entire stationary body 
through both feet at frequency of 30 Hz can also occur in 
a vertical orientation, known as the synchronous WBV. 
Most protocols call for maximum vertical acceleration, 
Apeak, during up stroke, of 0.5  g above the gravitational 
level of 9.8–14.7 m/s2, and reduction by 0.5 g below the 
gravitational level to 4.9  m/s2 during down stroke. At 
30 Hz, such WBV is equivalent to planet Earth expand-
ing its mass by 50 % and then immediately shrinking it by 
50  % every 0.033  s. Obviously, this condition has never 
occurred in Earth’s 4.54-billion-year history. Muscu-
lar activity is what typically causes such cyclic strains in 
bone. In other words, WBV may “fool” the bones of the 
body into believing that strenuous exercise is occurring, 
without the muscles actually having to do the work.
These data from the db/db mouse model are compel-
ling and strongly indicate that WBV has beneficial effects 
on glucose metabolism in young adult type 2 diabetic 
mice. The reason for improved glycemic status in this 
study is not clear. We speculate osteocyte-dependent 
process as a likely contributor. Lee et  al. first reported 
that skeleton regulates the insulin/glucose axis and 
energy metabolism (Lee et al. 2007). The Bone behaves as 
an endocrine organ by secreting osteocalcin, which leads 
to lower blood glucose and increase β-cell mass, insulin 
secretion and sensitivity. Thus, osteocalcin was consid-
ered as a treatment for T2DM (Ferron et al. 2012). Recent 
clinical reports have confirmed that patients with T2DM, 
indeed, have lower osteocalcin levels compared to nor-
mal controls (Kanazawa et  al. 2009). Moreover, Fernán-
dez-Real et al. proposed that osteocalcin represents this 
missing link in the exercise-induced improvement in 
insulin sensitivity, and exercise may stimulate increased 
secretion of osteocalcin by the bone (Fernandez-Real 
et al. 2009). Meanwhile, it has been shown that WBV can 
potentiate bone’s anabolic responsiveness by biasing the 
differentiation and proliferation of mesenchymal stem 
cells in the marrow towards osteoblastogenesis (Luu et al. 
2009). And osteocalcin, one of the very few osteoblast-
specific proteins, comes from mature osteoblasts. Impor-
tantly, recently published data confer a newer model of 
pathogenesis for T2DM, postulating a state of low-grade 
inflammation preceding the acquisition of insulin intoler-
ance; Zeng et al. (2012) describe a contributory role that 
an imbalance of pro- and anti-inflammatory T-cells may 
play in the development of T2DM. In this study we were 
able to show a reduced pro-inflammatory profile and less 
cytotoxicity under WBV condition which theoretically 
could be related to increased osteocalcin levels. Although 
osteocalcin levels were not measured in this study, clini-
cal reports have corroborated the notion that patients 
with T2DM indeed have lower osteocalcin levels com-
pared to the normal controls (Zhou et al. 2009). In a large 
study of 4047 men 70  years or older, Yeap et  al. (2010) 
found that reduced total serum osteocalcin was inversely 
related to waist circumference, serum glucose level, 
serum triglyceride level, metabolic syndrome, and insu-
lin resistance. It is thus tempting to speculate that WBV-
induced euglycemic effects reflect an osteocyte-mediated 
increase in osteoblast release of osteocalcin, with conse-
quently reduced inflammatory profile and cytotoxicity, 
ultimately leading to better insulin sensitivity. Impor-
tantly, in our experiment HbA1c levels were reduced in 
vibrated db/db group, and our metabolic cage study is 
supportive of improved glycemic status. This conten-
tion is supported by the observation of reduction in fluid 
intake, urine excretion output and improved urinary con-
centrating ability. These are relevant results, despite the 
small sample sizes, as indicated by the large Effective Size 
Indices. Accordingly, lower glucose levels may have led to 
a decrease in water intake, less urine output and increase 
in urine osmolality.
Consistent with the improvement of glyce-
mic status, WBV exerted beneficial effects on 
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indices of inflammation and cell injury. This contention 
is supported by the reduction in IL-17 positive cells but 
increased in Foxp3 positive cells as well as marked reduc-
tion in cells positive for gammaH2AX in peripheral 
blood of db/db, but not db/m, mice subjected to WBV. 
In our previous investigation of diabetic nephropathy, we 
showed marked increase in immunostaining of gamma-
H2AX in renal tissue of db/db than db/m mice (Mozaffari 
et al. 2012). Further, renal cells prepared from kidneys of 
db/db mice showed marked increase in percent of IL-17 
positive cells compared to their db/m control (Baban 
et al. 2013b). In light of results of the present study, sub-
sequent studies should establish whether WBV benefi-
cially influences indices of inflammation and cell injury 
in target organs, such as the kidney, which are adversely 
impacted by diabetes.
In conclusion, the results of present study indicate 
that WBV improves glycemic status in association with 
improvement in indices of inflammation and cell injury 
in db/db mice, a very relevant animal model of T2DM. 
Thus, beneficial impact of WBV should be further 
explored in both pre-clinical and clinical studies espe-
cially in overweight or obese young adults with pre-dia-
betes or type 2 diabetes.
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